GDF2 and prostate cancer: Previous reports have shown that BMP9 as pleiotropic cytokine can significantly reduce the proliferation of MG-63 cells and HOS osteosarcoma cells in a time-dependent manner, and prevents the migration and invasiveness of prostate cancer [27].